Publication:
Corrigendum: Cost-Effective, Safe, and Personalized Cell Therapy for Critical Limb Ischemia in Type 2 Diabetes Mellitus.

Simple item page
dc.contributor.authorSoria-Juan, Bárbara
dc.contributor.authorEscacena, Natalia
dc.contributor.authorCapilla-González, Vivian
dc.contributor.authorAguilera, Yolanda
dc.contributor.authorLlanos, Lucía
dc.contributor.authorTejedo, Juan R
dc.contributor.authorBedoya, Francisco J
dc.contributor.authorJuan, Verónica
dc.contributor.authorDe la Cuesta, Antonio
dc.contributor.authorRuiz-Salmerón, Rafael
dc.contributor.authorAndreu, Enrique
dc.contributor.authorGrochowicz, Lukas
dc.contributor.authorPrósper, Felipe
dc.contributor.authorSánchez-Guijo, Fermín
dc.contributor.authorLozano, Francisco S
dc.contributor.authorMiralles, Manuel
dc.contributor.authorDel Río-Solá, Lourdes
dc.contributor.authorCastellanos, Gregorio
dc.contributor.authorMoraleda, José M
dc.contributor.authorSackstein, Robert
dc.contributor.authorGarcía-Arranz, Mariano
dc.contributor.authorGarcía-Olmo, Damián
dc.contributor.authorMartín, Franz
dc.contributor.authorHmadcha, Abdelkrim
dc.contributor.authorSoria, Bernat
dc.contributor.authorCollaborative Working Group “Noma Project Team”
dc.date.accessioned2023-02-09T09:42:01Z
dc.date.available2023-02-09T09:42:01Z
dc.date.issued2020-09-02
dc.description.abstract[This corrects the article DOI: 10.3389/fimmu.2019.01151.].
dc.identifier.doi10.3389/fimmu.2020.02029
dc.identifier.essn1664-3224
dc.identifier.pmcPMC7492973
dc.identifier.pmid32983148
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7492973/pdf
dc.identifier.unpaywallURLhttps://www.frontiersin.org/articles/10.3389/fimmu.2020.02029/pdf
dc.identifier.urihttp://hdl.handle.net/10668/16331
dc.journal.titleFrontiers in immunology
dc.journal.titleabbreviationFront Immunol
dc.language.isoen
dc.organizationCentro Andaluz de Biología Molecular y Medicina Regenerativa-CABIMER
dc.organizationFundación Pública Andaluz Progreso y Salud-FPS
dc.organizationHospital Universitario Virgen Macarena
dc.page.number2029
dc.pubmedtypePublished Erratum
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectcell-based therapy
dc.subjectcellular medicaments
dc.subjectclinical trials
dc.subjectcost-effective
dc.subjectcritical limb ischemia
dc.subjectdiabetes
dc.titleCorrigendum: Cost-Effective, Safe, and Personalized Cell Therapy for Critical Limb Ischemia in Type 2 Diabetes Mellitus.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number11
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
PMC7492973.pdf
Size:
113.87 KB
Format:
Adobe Portable Document Format
Download

Collections

Centro Andaluz de Biología Molecular (CABIMER)
Fundación Pública Andaluza Progreso y Salud
SAS - Hospital Universitario Virgen Macarena

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía